Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.

Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss drugs like Zepbound and Novo Nordisk's Ozempic ...

The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey. The investment bank polled 27 health maintenance organizations ...

Denenberg, the chief of pediatrics with Corewell, says the Neonatal Intensive Care Unit is nearly at capacity as well.

A federal appeals court ruled Thursday that the Justice ... Attorney General Merrick Garland said in a letter to Congress on Wednesday that he planned to release the election interference-related ...

The GLP-1s semaglutide and tirzepatide marketed by NVO and LLY as Ozempic/Wegovy and Mounjaro/Zepbound, respectively, for type 2 diabetes and weight loss, are expected to generate more than $70B ...